These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38388872)

  • 21. Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study.
    Gunaratne AW; Hamblin H; Clancy A; Magat AJMC; Dawson MVM; Tu J; Borody TJ
    Helicobacter; 2021 Oct; 26(5):e12830. PubMed ID: 34247436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized clinical trial: 7-day vonoprazan-based versus 14-day omeprazole-based triple therapy for Helicobacter pylori.
    Bunchorntavakul C; Buranathawornsom A
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3308-3313. PubMed ID: 34622504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility.
    Okubo H; Akiyama J; Kobayakawa M; Kawazoe M; Mishima S; Takasaki Y; Nagata N; Shimada T; Yokoi C; Komori S; Kimura K; Hisada Y; Iwata E; Watanabe K; Yanagisawa N; Shiroma S; Shimomura A; Okahara K; Cho H; Uemura N
    J Gastroenterol; 2020 Nov; 55(11):1054-1061. PubMed ID: 32930864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.
    Sakurai Y; Shiino M; Okamoto H; Nishimura A; Nakamura K; Hasegawa S
    Adv Ther; 2016 Sep; 33(9):1519-35. PubMed ID: 27432383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Vonoprazan Triple-Drug Blister Packs on H. pylori Eradication Rates in Japan: Interrupted Time Series Analysis.
    Deguchi H; Yamazaki H; Kamitani T; Yamamoto Y; Fukuhara S
    Adv Ther; 2021 Jul; 38(7):3937-3947. PubMed ID: 34091865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vonoprazan-based therapies versus PPI-based therapies in patients with H. pylori infection: Systematic review and meta-analyses of randomized controlled trials.
    Liu L; Shi H; Shi Y; Wang A; Guo N; Li F; Nahata MC
    Helicobacter; 2024; 29(3):e13094. PubMed ID: 38790090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
    Graham DY; Lu H; Shiotani A
    J Gastroenterol Hepatol; 2021 May; 36(5):1159-1163. PubMed ID: 32918832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy.
    Ozaki H; Harada S; Takeuchi T; Kawaguchi S; Takahashi Y; Kojima Y; Ota K; Hongo Y; Ashida K; Sakaguchi M; Tokioka S; Sakamoto H; Furuta T; Tominaga K; Higuchi K
    Digestion; 2018; 97(3):212-218. PubMed ID: 29393194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vonoprazan-amoxicillin dual therapy for
    Zhou BG; Mei YZ; Jiang X; Zheng AJ; Ding YB
    Saudi J Gastroenterol; 2023; 29(6):347-357. PubMed ID: 37602635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
    Ouyang Y; Wang M; Xu YL; Zhu Y; Lu NH; Hu Y
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1666-1672. PubMed ID: 35716370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
    Horie R; Handa O; Ando T; Ose T; Murakami T; Suzuki N; Sendo R; Imamoto E; Itoh Y
    Helicobacter; 2020 Aug; 25(4):e12698. PubMed ID: 32368846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vonoprazan-amoxicillin dual regimen with
    Dirjayanto VJ; Audrey J; Simadibrata DM
    World J Gastroenterol; 2024 Mar; 30(10):1280-1286. PubMed ID: 38596495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study: Vonoprazan and proton pump inhibitors in
    Sakurai K; Suda H; Ido Y; Takeichi T; Okuda A; Hasuda K; Hattori M
    World J Gastroenterol; 2017 Jan; 23(4):668-675. PubMed ID: 28216974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.
    Tanabe H; Ando K; Sato K; Ito T; Goto M; Sato T; Fujinaga A; Kawamoto T; Utsumi T; Yanagawa N; Ichiishi E; Otake T; Kohgo Y; Nomura Y; Ueno N; Sugano H; Kashima S; Moriichi K; Fujiya M; Okumura T
    Dig Dis Sci; 2017 Nov; 62(11):3069-3076. PubMed ID: 28664410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates.
    Graham DY
    Dig Dis Sci; 2023 May; 68(5):1691-1697. PubMed ID: 36856926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and Safety of Vonoprazan versus Proton Pump Inhibitors for Second-Line Helicobacter pylori Eradication Therapy: Systematic Review and Meta-Analysis.
    Shinozaki S; Kobayashi Y; Osawa H; Sakamoto H; Hayashi Y; Lefor AK; Yamamoto H
    Digestion; 2021; 102(3):319-325. PubMed ID: 31914442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vonoprazan-Based Triple-Therapy Could Improve Efficacy of the Tailored Therapy of Helicobacter pylori Infection.
    Shinmura T; Adachi K; Yamaguchi Y; Izawa S; Hijikata Y; Ebi M; Funaki Y; Ogasawara N; Sasaki M; Kasugai K
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):389-395. PubMed ID: 31826057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials.
    Yang C; Li S; Huang T; Lin H; Jiang Z; He Y; Yuan J; An H
    J Clin Pharm Ther; 2022 Jul; 47(7):897-904. PubMed ID: 35247003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy.
    Suzuki S; Gotoda T; Kusano C; Iwatsuka K; Moriyama M
    Am J Gastroenterol; 2016 Jul; 111(7):949-56. PubMed ID: 27185079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking and Drinking Did Not Increase the Failure of Therapeutic Helicobacter pylori Eradication by Vonoprazan, Clarithromycin, and Amoxicillin.
    Takara Y; Endo H; Nakano R; Kawachi K; Hidaka H; Matsunaga T; Tsuruoka N; Sakata Y; Shimoda R; Hara M; Fujimoto K
    Digestion; 2019; 99(2):172-178. PubMed ID: 30179876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.